Tenax Therapeutics, Inc. TENX
1.69 USD -0.09 (-5.06%)
At closeNov 10, 2026, 4:46 PM EST
1.68 -0.01 -0.33%
After hours · Nov 10, 4:46 PM ET
1.62 Day range 1.77
1.31 52-week range 19.40
- YTD
- -86.14%
- 1 year
- -75.82%
News
prnewswire.com What's Next for Tenax Therapeutics, Inc. Shareholders After 89.77% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline Complaint alleges Tenax Therapeutics, Inc. misled investors between November 13, 2023 and August 7, 2026; investors may seek lead plaintiff role by December 28, 2026 LOS ANGELES, Nov. 10, 2026…
globenewswire.com TENX Shareholder Alert: Tenax Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt Guggenheim Securities cut its Tenax price target 90%, and two other firms downgraded TENX, after the Phase 3 LEVEL trial of TNX-103 failed. The lawsuit claims this study was wrongly promoted to…
businesswire.com Robbins LLP Urges TENX Investors Who Lost Money Investing in Tenax Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action SAN DIEGO--(BUSINESS WIRE)---- $TENX #TENX--Tenax Therapeutics, Inc. faces allegations it misled investors regarding the viability of its drug candidate levosimendan.
globenewswire.com TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law LOS ANGELES, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tenax…
gurufocus.com TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS LawPR NewswireLOS ANGELES, Nov. 9, 2026LOS ANGELES, Nov. 9, 2026 /
prnewswire.com TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law LOS ANGELES, Nov. 9, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of…
newsfilecorp.com ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX New York, New York--(Newsfile Corp. - November 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between…
newsfilecorp.com TENX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics (TENX) Investors of Securities Class Action Lawsuit Deadline on December 28, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tenax To Contact Him Directly To Discuss Their Options If you purchased or acquired…
prnewswire.com TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit NEW YORK, Nov. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023…
globenewswire.com ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX NEW YORK, Nov. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13,…
newsfilecorp.com ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX New York, New York--(Newsfile Corp. - November 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between…
prnewswire.com TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law LOS ANGELES, Nov. 6, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of…
prnewswire.com Tenax Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TENX NEW YORK, Nov. 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. ("Tenax" or "the Company") (NASDAQ: TENX) for violations of…
newsfilecorp.com Kaplan Fox Alerts Investors of Tenax Therapeutics, Inc. (TENX) with Significant Losses to a Securities Class Action Deadline on December 28, 2026 New York, New York--(Newsfile Corp. - November 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company")…
newsfilecorp.com ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX New York, New York--(Newsfile Corp. - November 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between…
prnewswire.com Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENX NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) and certain…
prnewswire.com TENX Shareholder Alert: Tenax Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt Notice to Pension Funds, Asset Managers, and Fiduciaries: the lawsuit alleges Tenax overstated TNX-103's clinical prospects while raising $134 million, largely through private placements, before its…
newsfilecorp.com TENX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics (TENX) Investors of Securities Class Action Lawsuit Deadline on December 28, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tenax To Contact Him Directly To Discuss Their Options If you purchased or acquired…
benzinga.com Tenax Therapeutics Q3 EPS $(0.31) Beats $(0.40) Estimate Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.40) by 20.51 percent. This is a 22.5 percent increase over losses of…
globenewswire.com Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Completed Statistical Analyses of LEVEL Yielded a Predictive Enrichment Strategy Being Applied in Amended LEVEL-2 Protocol Company Has Been Granted a Type C Meeting with the FDA CHAPEL HILL, N.C.,…
globenewswire.com ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc.…
newsfilecorp.com ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX New York, New York--(Newsfile Corp. - November 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax…
businesswire.com Deadline Alert: Tenax Therapeutics, Inc. Shareholders Have Until December 28, 2026 to Seek Lead Plaintiff Appointment in Securities Fraud Lawsuit, The Law Offices of Frank R. Cruz Notes LOS ANGELES--(BUSINESS WIRE)--The deadline for Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) investors to seek appointment as lead plaintiff in a securities class action lawsuit…
newsfilecorp.com CLASS ACTION NOTICE: Berger Montague Advises Tenax Therapeutics, Inc. (TENX) Investors to Inquire About a Securities Fraud Class Action Philadelphia, Pennsylvania--(Newsfile Corp. - November 4, 2026) - Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ:…
globenewswire.com SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses.
newsfilecorp.com Did You Lose Money Investing in Tenax Therapeutics, Inc.? Robbins LLP Urges Investors with Large Losses to Contact the Firm for Information About Their Rights Against TENX San Diego, California--(Newsfile Corp. - November 4, 2026) - Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who…
prnewswire.com Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 28, 2026 in Tenax Therapeutics, Inc. Lawsuit - TENX Key Dates and Disclosure Events: a 33-month Tenax timeline traces how the Company allegedly built confidence in TNX-103 across three financings before its Phase 3 LEVEL trial missed its primary…
newsfilecorp.com Kaplan Fox Alerts Tenax Therapeutics, Inc. (TENX) Investors Who Suffered Losses to a Securities Class Action - Deadline is December 28, 2026 New York, New York--(Newsfile Corp. - November 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company")…
newsfilecorp.com TENX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics (TENX) Investors of Securities Class Action Lawsuit Deadline on December 28, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tenax To Contact Him Directly To Discuss Their Options If you purchased or acquired…
newsfilecorp.com ROSEN, LEADING INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX New York, New York--(Newsfile Corp. - November 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax…
globenewswire.com Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers – TENX NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) and certain…
newsfilecorp.com SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (TENX) - Investors Who Suffered Losses Are Encouraged to Contact the Firm Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses.
businesswire.com Securities Fraud Class Action Filed Against Tenax Therapeutics, Inc.: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline LOS ANGELES--(BUSINESS WIRE)--A securities fraud class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) on behalf of investors who purchased or…
businesswire.com Securities Fraud Class Action Lawsuit Pending Against Tenax Therapeutics, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline BENSALEM, Pa.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased…
globenewswire.com SueWallSt Reminds Tenax Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 28, 2026 - TENX A securities fraud class action puts the Tenax promise-reality gap on the record. Management pointed to a 29-meter Phase 2 walk result, while the lawsuit claims TNX-103 was less effective than…
globenewswire.com TENX INVESTOR NOTICE: RGRD Law Announces that Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ: TENX) securities between November 13, 2023…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…
benzinga.com 5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month U.S. stocks settled lower on Monday, with the Dow Jones index falling more than 350 points during the session. Renewed US-Iran strikes over the weekend sent crude sharply higher Monday, reviving…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regular session. The company's market cap stands at $4.0 million. CollPlant Biotechnologies (NASDAQ:CLGN)…
benzinga.com This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
benzinga.com Reported Earlier, Tenax Reports New Phase 3 Data Supporting TNX-103 In Pulmonary Hypertension Patients Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company") today announced that additional results from the Phase 3 LEVEL clinical trial evaluating TNX-103 (oral
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million. Biodexa…
- benzinga.com Chardan Capital Downgrades Tenax Therapeutics to Neutral, Lowers Price Target to $5 Chardan Capital analyst Gautam Chukka downgrades Tenax Therapeutics (NASDAQ:TENX) from Buy to Neutral and lowers the price target from $27 to $5.
benzinga.com Guggenheim Maintains Buy on Tenax Therapeutics, Lowers Price Target to $4 Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and lowers the price target from $40 to $4.
benzinga.com Evercore ISI Group Downgrades Tenax Therapeutics to In-Line, Lowers Price Target to $5 Evercore ISI Group analyst Gavin Clark-Gartner downgrades Tenax Therapeutics (NASDAQ:TENX) from Outperform to In-Line and lowers the price target from $39 to $5.- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regular session. The market value of their outstanding shares is at $16.8 million. As per the press release,…
benzinga.com Crude Oil Surges 3%; Sionna Therapeutics Shares Plunge US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National Energy Services up 16% on strong earnings.
benzinga.com Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.
benzinga.com US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dropped 0.9%. Monday.com shares fell 10%.